Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
I. Aayishamma
Observed name:
Aayishamma I
ORCID:
0009-0009-6053-8359
Observed ORCID:
0009-0009-6053-8359
OpenAlex ID:
A5099420404
An insight into sustainable and green chemistry approaches for the synthesis of quinoline derivatives as anticancer agents
2024
·
B. Kumaraswamy
, K. Hemalatha
, et al.
·
European Journal of Medicinal Chemistry
·
46
Benzothiazole a privileged scaffold for Cutting-Edges anticancer agents: Exploring drug design, structure-activity relationship, and docking studies
2024
·
Aayishamma I
, Gurubasavaraja Swamy Purawarga Matada
, et al.
·
European Journal of Medicinal Chemistry
·
40
Pyrazole, Pyrazoline, and Fused Pyrazole Derivatives: New Horizons in EGFR‐Targeted Anticancer Agents
2024
·
Ketan R Hosamani
, Hemalatha K
, et al.
·
Chemistry & Biodiversity
·
35
Expanding the potential of pyridine scaffold for targeted therapy of cancer: Biological activity, molecular insights, and structure-activity relationship
2024
·
Nimmagadda Venkata Satya Sai Aishwarya
, Gurubasavaraja Swamy Purawarga Matada
, et al.
·
Journal of Molecular Structure
·
24
Exploring the Anticancer Potential of Triazine Derivatives: An Outlook of Designing Strategies, Docking Studies, and Structure‐Activity Relationships (SAR)
2024
·
B. V. Manjushree
, Gurubasavaraja Swamy Purawarga Matada
, et al.
·
ChemistrySelect
·
7
Advancements of anticancer agents by targeting the Hippo signalling pathway: biological activity, selectivity, docking analysis, and structure–activity relationship
2024
·
E. Haripriya
, K. Hemalatha
, et al.
·
Molecular Diversity
·
4
Show more works
View as search
Works count:
6
Citation count:
156
H-index:
5
I10-index:
4
Year
Topic
Type
